Zelira Therapeutics Ltd
F:G1G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zelira Therapeutics Ltd
F:G1G
|
AU |
|
R
|
Regina Miracle International (Holdings) Ltd
SWB:RMT
|
HK |
|
K
|
Kyowa Kirin Co Ltd
SWB:KY4
|
JP |
|
Bank Ochrony Srodowiska SA
F:967
|
PL |
|
China Evergrande New Energy Vehicle Group Ltd
F:4NM1
|
CN |
|
O
|
Okada Aiyon Corp
TSE:6294
|
JP |
|
E
|
Ellcot Spinning Mills Ltd
KAR:ELSM
|
PK |
|
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
|
CN |
|
Romerike Sparebank
F:92I
|
NO |
|
V
|
Viking Tech Corp
TPEX:3624
|
TW |
|
T
|
Tung Thih Electronic Co Ltd
TPEX:3552
|
TW |
|
S
|
Sensorion SA
XMUN:RFM
|
FR |
|
J
|
JS Investments Ltd
KAR:JSIL
|
PK |
Bankruptcy Probability
Zelira Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zelira Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Zelira Therapeutics Ltd
ASX:ZLD
|
6.6m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
368B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
297.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zelira Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zelira Therapeutics Ltd has total debt of 2m AUD. This includes both short-term (2m AUD) and long-term (0 AUD) debt.
You can find a full breakdown on its Balance Sheet.
